TCL Archive FDA Approval of Abraxane Sets Stage for Competition Between Taxane Drugs. Abraxane a Nanotechnology Drug? Sponsor Says Yes, FDA Says. January 14, 2005
TCL Archive NCI Anticipates 60% Decline In Number Of New Trials By Cooperative Groups. January 12, 2007
TCL Archive ASCO Annual Meeting: New Approaches For Treatment of Hematologic Malignancies June 30, 2006
